Company Search:
Advanced Search
Sponsored Links
Lupin Ltd Company Snapshot
Lupin Ltd operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lupin Ltd with three other pharmaceutical manufacturers in Asia: Green Cross Holdings Corporation of South Korea (2016 sales of 1.35 trillion Korean Won [US$1.18 billion] ), Kangmei Pharmaceutical Co Ltd of China (21.61 billion Chinese Renmimbi [US$3.14 billion] of which 87% was Medicine), and Hisamitsu Pharmaceutical Co Inc which is based in Japan (161.85 billion Japanese Yen [US$1.49 billion] of which 100% was Pharmaceuticals).

Sales Analysis. Lupin Ltd reported sales of 142.08 billion Indian Rupees (US$2.20 billion) for the fiscal year ending March of 2016. This represents an increase of 11.3% versus 2015, when the company's sales were 127.70 billion Indian Rupees. Sales at Lupin Ltd have increased during each of the previous five years (and since 2011, sales have increased a total of 149%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Lupin Ltd
  Stock Performance Chart for Lupin Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/21/2017): 1,407.85
(Figures in Indian Rupees)
1 Week -1.9%   13 Weeks -5.4%  
4 Weeks -3.9%   52 Weeks -9.6%  
Lupin Ltd Key Data:
  Ticker: LUPIN Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 142,084,700,000
(Year Ending Jan 2017).
Employees: 20,587
  Currency: Indian Rupees Market Cap: 635,752,495,022
  Fiscal Yr Ends: March Shares Outstanding: 451,576,869
  Share Type: Ordinary Closely Held Shares: 225,658,795
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.